Bitron Limited Underway to Evaluate Compounds Against Coronavirus

  • Feb 06, 2020 AEDT
  • Team Kalkine

Engaged in the R&D and commercialization of drugs pertaining to viral diseases with unmet medical needs, Bitron Limited (ASX:BIT) has come into limelight for the ongoing crisis of coronavirus-

  • The Company is in process of evaluating several promising compounds for activity against coronavirus
  • It has over 30 compounds with good activity against a range of coronaviruses and is focused on testing a select set of these compounds against the new 2019-nCoV

The stock surged by over 15% and is priced at $0.095 as at 1:04 PM AEST on the ASX.



All pictures are copyright to their respective owner(s) does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK